The upregulated expression of the epithelial to mesenchymal transition genes CAMK2N1 and WNT5A is associated with the progression of prostate cancer (Peng et al., 2021; Wang et al., 2014; Zhang et al., 2022b). This evidence concerns the gene CAMK2N1 and prostate cancer.